RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Clinical trials for RECURRENT GENITAL HERPES SIMPLEX TYPE 2 explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GENITAL HERPES SIMPLEX TYPE 2 trials appear
Sign up with your email to follow new studies for RECURRENT GENITAL HERPES SIMPLEX TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human tests for experimental herpes drug show promise
Disease control CompletedThis early-stage study tested the safety and how the body processes a new experimental drug called ABI-5366. It involved 115 healthy volunteers and people with recurrent genital herpes. The main goals were to check for side effects, measure drug levels in the blood, and see if th…
Matched conditions: RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated Apr 02, 2026 06:11 UTC
-
First human tests for new herpes treatment complete
Disease control CompletedThis early-stage study tested the safety and how the body processes a new drug called ABI-1179. It involved 103 healthy volunteers and people with recurrent genital herpes caused by HSV-2. The main goal was to see if the drug was safe and to measure its levels in the blood over t…
Matched conditions: RECURRENT GENITAL HERPES SIMPLEX TYPE 2
Phase: PHASE1 • Sponsor: Assembly Biosciences • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC